GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 23-014_000 Erasmus MC Multicenter, Open-label, Phase 1 Study of Allo-RevCAR01-T-CD123 Consisting of Genetically Modified T Cells Carrying Reverse Chimeric Antigen Receptors (Allo-RevCAR01-T) in Combination with CD123 Target Module (R-TM123) for the Treatment of Patients with Selected Hematologic MalignanciesPositive for CD123 Ontwerpbesluit genomen
IM-MV 23-015_000 UMCG Multicenter, Open-label, Phase 1 Study of Allo-RevCAR01-T-CD123 Consisting of Genetically Modified T Cells Carrying Reverse Chimeric Antigen Receptors (Allo-RevCAR01-T) in Combination with CD123 Target Module (R-TM123) for the Treatment of Patients with Selected Hematologic Malignancies Positive for CD123 Ontwerpbesluit genomen
IM-MV 23-017_000 Amsterdam UMC Multicenter, Open-label, Phase 1 Study of Allo-RevCAR01-T-CD123 Consisting of Genetically Modified T Cells Carrying Reverse Chimeric Antigen Receptors (Allo-RevCAR01-T) in Combination with CD123 Target Module (R-TM123) for the Treatment of Patients with Selected Hematologic MalignanciesPositive for CD123 Ontwerpbesluit genomen